These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2001577)

  • 21. The crisis in clinical cancer research. Third-party insurance and investigational therapy.
    Antman K; Schnipper LE; Frei E
    N Engl J Med; 1988 Jul; 319(1):46-8. PubMed ID: 3288868
    [No Abstract]   [Full Text] [Related]  

  • 22. Assigning care costs associated with therapeutic oncology research: a modest proposal.
    Friedman MA; McCabe MS
    J Natl Cancer Inst; 1992 May; 84(10):760-3. PubMed ID: 1573661
    [No Abstract]   [Full Text] [Related]  

  • 23. Cooperative groups say NCI trials funding inadequate; some turn to industry.
    Schmidt C
    J Natl Cancer Inst; 2007 Jun; 99(11):830-1, 837. PubMed ID: 17551138
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.
    Bennett CL; Stinson TJ; Vogel V; Robertson L; Leedy D; O'Brien P; Hobbs J; Sutton T; Ruckdeschel JC; Chirikos TN; Weiner RS; Ramsey MM; Wicha MS
    J Clin Oncol; 2000 Aug; 18(15):2805-10. PubMed ID: 10920127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical hyperthermia in the 1990s: does the buck stop here?
    Sapozink MD
    Int J Hyperthermia; 1994; 10(3):395-401. PubMed ID: 7930806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NCI seeks to boost study participation.
    Merz B
    JAMA; 1988 Sep; 260(10):1337. PubMed ID: 3404584
    [No Abstract]   [Full Text] [Related]  

  • 29. Popping the cost balloon. Angioplasty study should be a harbinger, but budgets, entropy stall reform.
    Sloane T
    Mod Healthc; 2007 Apr; 37(15):21. PubMed ID: 17494354
    [No Abstract]   [Full Text] [Related]  

  • 30. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of physician reimbursement reform: patient access and physicians' practice.
    Adams EK
    J Med Pract Manage; 1986; 2(1):19-23. PubMed ID: 10301546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer patient care in clinical trials sponsored by the National Cancer Institute: what does it cost?
    Brown ML
    J Natl Cancer Inst; 1999 May; 91(10):818-9. PubMed ID: 10340896
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of clinical trial protocols on patient care in a community hospital.
    McKenna RJ
    Cancer; 1993 Nov; 72(9 Suppl):2828-33. PubMed ID: 8402513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association.
    McCaskill-Stevens W; Pinto H; Marcus AC; Comis R; Morgan R; Plomer K; Schoentgen S
    J Clin Oncol; 1999 Mar; 17(3):1029-39. PubMed ID: 10071298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitating clinical trials. The expanding role of the nurse.
    Engelking C
    Cancer; 1991 Mar; 67(6 Suppl):1793-7. PubMed ID: 2001580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gore champions major new cancer initiative.
    Castellucci L
    J Natl Cancer Inst; 1998 Feb; 90(4):270. PubMed ID: 9486811
    [No Abstract]   [Full Text] [Related]  

  • 37. A Time-Trend Economic Analysis of Cancer Drug Trials.
    Cressman S; Browman GP; Hoch JS; Kovacic L; Peacock SJ
    Oncologist; 2015 Jul; 20(7):729-36. PubMed ID: 26032135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardization, more funds on horizon for clinical trials.
    McNeil C
    J Natl Cancer Inst; 2005 Apr; 97(8):555-7. PubMed ID: 15840874
    [No Abstract]   [Full Text] [Related]  

  • 39. Physician collaboration with payers: an important step on the road to optimum patient care.
    Patti JA
    J Am Coll Radiol; 2006 Mar; 3(3):187-9. PubMed ID: 17412037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The need for Diagnosis-Related Group 471. Protection for clinical research.
    Yarbro JW; Mortenson LE
    JAMA; 1985 Feb; 253(5):684-5. PubMed ID: 3918185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.